Although several multi-center studies have demonstrated that serum IGF-I predicts the outcome of patients with BC (48–50) and others (51,52) observed the correlation between high IGF-I mRNA levels and longer OS and DFS in cases of BC, this was not assessed in TNBC. This evidence concerns the gene IGF1 and breast cancer.